ASPECTS as a clinical outcome marker for MCA infarction treated with thrombolytic therapy: Non-contrast CT versus CTA source images

Creative Commons License

Ger Akarsu F., Sezer Eryildiz E., AYKAÇ Ö., Uysal Kocabaş Z., ÖZDEMİR A. Ö.

Neurology Asia, cilt.27, sa.2, ss.247-253, 2022 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.54029/2022kmj
  • Dergi Adı: Neurology Asia
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE
  • Sayfa Sayıları: ss.247-253
  • Anahtar Kelimeler: Acute stroke, thrombolytic therapy, neuroimaging, ACUTE ISCHEMIC-STROKE, NONCONTRAST COMPUTED-TOMOGRAPHY, TISSUE-PLASMINOGEN ACTIVATOR, ENDOVASCULAR TREATMENT, ANGIOGRAPHY, EXTENT, TRIAL, REVASCULARIZATION, RELIABILITY, OCCLUSION
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

© 2022, ASEAN Neurological Association. All rights reserved.Background & Objective: Computed tomography angiography (CTA) in acute stroke has been widely used to demonstrate arterial occlusion. Alberta Stroke Program Early CT Score (ASPECTS) is used to detect early ischemic signs in non-contrast computed tomography (NCCT) in the middle cerebral artery region. We hypothesized that computed tomography angiography source image (CTA-SI) is superior to NCCT in predicting final infarct volume, 24 hour National Institutes of Health Stroke Scale (NIHSS) score and 90-day clinical outcome. Methods: Patients who had an acute ischemic stroke due to middle cerebral artery (MCA) occlusion and treated with tissue plasminogen activator (tPA) were retrospectively evaluated. ASPECTS was evaluated by two experienced stroke neurologists in acute NCCT, CTA-SI, and follow up imaging. The final ASPECTS was compared with the mean baseline ASPECTS of NCCT and CTA-SI. The relation of both scores with 24-hour NIHSS and clinical outcome was compared. The Modified Rankin Scale (mRS) was utilized to evaluate the 90-day outcomes. mRS score of 0-2 was considered a “good outcome”. Results: Fifty-three patients were evaluated. We observed a significant relation among CTA-SI ASPECTS and after treatment 24hr ASPECTS (y=-3.9 + 1.4 x; 95% CI,-7.6 to-0.2) (y=-26.04 + 3.5 x; CI,-41 to-10). The median baseline 24-hr NHISS was 6 (0-22). We found a better correlation between CTA-SI ASPECTS and 24-hr NHISS (y= 363.06 +-37.03 x; CI,-148 to 864) than between NCCT ASPECTS and 24h NHISS (y=529.80 +-62.55 x; CI, 180-829). Median 90 days mRS score was 2 (0-6). According to Deming regression analysis, the CTA-SI ASPECTS (y= 76.10 +-7.69 x; 95% CI,-36 to 188) was more consistent with the 90 day mRS compared to NCCT ASPECTS (y=149.86 +-17.67 x; 95% CI, 23-267) CTA-SI was superior in predicting 24hr NIHSS and day 90 mRS compared to NCCT ASPECTS. Conclusion: Prediction of CTA-SI ASPECTs is better than NCCT ASPECTs at 24hr NIHSS, 3-month mRS and final infarct size in acute ischemic stroke patients treated with tPA.